Svedbom et al. [26] in a systematic review of real-world evidence in immune-mediated rheumatic diseases including RA, examined the persistence to treatment with s.c. GLM but also to other anti-TNFα molecules. This evidence concerns the gene TNF and rheumatoid arthritis.